1-T cell targeting chimeric antigen receptor (CAR) regulatory T cells (Tregs) for graft-versus-host-disease (GvHD) prevention
Dre Chiara Bernardi, Departement d’Oncologie HUG

2-153sm-fapi-46 radioligand therapy with high-molar activity 153s
Dr Thierry Sora, CERN

3-Counteracting Progression Mechanisms to Overcome Immune Checkpoint Inhibitor Resistance in Bladder Cancer
Dr. Hajar El Ahanidi  , Department of Pathology and Immunology UNIGE

4-Investigating the significance of a novel definition of tumora-associated macrophage polarization as an estimator of the tumor microenvironment state and prognostic tool in pancreatic ductal adenocarcinoma (PDAC)
Dr Marc Pfefferlé. Department de Pathologie et Immunologie UNIGE

5-POU5F1B, tumor microenvironment and colorectal cancer metastasis
Dre Laia Simo Riudalbas, Department of Medicine UNIGE

6-Personalized ultrahigh field MRI for prostate cancer
Dr Thomas de Perrot, Departement Diagnostique HUG

 7-Investigating PD-L1 expression as predictor of response to neo-adjuvant chemotherapy in hormone receptor positive breast cancer
Dre Anita Wolfer, Departement d’Oncologie HUG

Bourse MD-PhD
Natural Language Processing Framework for Oncology Reports
Dr Johann Pignat, Departement d’Oncologie HUG